A detailed history of Private Capital Group, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Private Capital Group, LLC holds 106 shares of UTHR stock, worth $37,770. This represents 0.02% of its overall portfolio holdings.

Number of Shares
106
Previous 106 -0.0%
Holding current value
$37,770
Previous $19,000 31.58%
% of portfolio
0.02%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 21, 2022

BUY
$166.16 - $213.96 $13,126 - $16,902
79 Added 292.59%
106 $19,000
Q4 2021

Jan 24, 2022

SELL
$184.32 - $216.08 $16,773 - $19,663
-91 Reduced 77.12%
27 $6,000
Q3 2021

Oct 13, 2021

BUY
$179.86 - $214.88 $16,906 - $20,198
94 Added 391.67%
118 $22,000
Q1 2021

Apr 12, 2021

SELL
$153.94 - $174.85 $307 - $349
-2 Reduced 7.69%
24 $4,000
Q4 2020

Jan 26, 2021

BUY
$101.87 - $151.79 $1,120 - $1,669
11 Added 73.33%
26 $4,000
Q2 2020

Aug 13, 2020

BUY
$92.74 - $125.82 $1,391 - $1,887
15 New
15 $2,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.2B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Private Capital Group, LLC Portfolio

Follow Private Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Capital Group, LLC with notifications on news.